|
|
Nanomaterials
The ability of scientists and researchers to manipulate matter at the smallest scales will increase the potential for new products to be stronger, lighter and cheaper. This process can be achieved through further research and a constructive partnership among the involved stakeholders. The end results will help fill in the gaps between science and knowledge. While there are still many questions to be answered in terms of safety, regulation and risk management, the short and long-term benefits of nanotechnology must be considered.
The chemical and pharmaceutical industries will benefit mostly from the innovative approach of nanotechnology. Medical intervention at the cellular and molecular level could help solve problems never before considered . With the help of quantum dots (semi-conducting nanocrystals) the cell activity could be better managed and new information could be provided. In this way, diseases such as cancer or heart failure could already be eradicated at the cell level. Nanotechnology will also be able to create an enhanced drug delivery system which could administer and monitor drug delivery and drug levels. Just as today we can live with an artificial heart, tomorrow’s nanotechnology could replace elements at cell level.
Nanotechnology has a growing technological and economic potential. Globalisation and the knowledge-driven economy require faster and further developments in the nanotech sector. Such potential developments are likely to be seen in DNA computers, catalysts, microelectronics, electronic waste, space exploration etc. The market application of these developments will require and provide new job opportunities. Nanotechnology is a multidisciplinary working field involving scientists, engineers and other specialists.These high qualification jobs will further enhance the EU knowledge base in the context of the Lisbon strategy. Further reading : |
|
|
||||||||||||
|
© Copyright 2009 Cefic - European Chemical Industry Council. All rights reserved. Terms and Conditions of Use |